经导管主动脉瓣置换术与增加严重症状性主动脉瓣狭窄治疗的价值:一份通俗语言总结
这份数据集提供了关于TAVR治疗SSAS的经济评估的通俗语言总结,包括净效益分析和患者分组比较。

基本信息
资源简介
经导管主动脉瓣置换术与增加严重症状性主动脉瓣狭窄治疗的价值:一份通俗语言总结
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 14 个文件、合计 14.98 MB,主题涵盖 Aortic stenosis、Economic evaluation、Treatment uptake、Value-for-money,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Transcatheter aortic valve replacement and the value of increasing treatment for severe symptomatic aortic stenosis: a plain language summary》。配套论文《Transcatheter aortic valve replacement and the value of increasing treatment for severe symptomatic aortic stenosis: a plain language summary》发表于 Journal of Medical Economics(2024),DOI:10.1080/13696998.2024.2403926。项目资助方:Funding was received from Edwards Lifesciences.。源站首次发布:2024-10-18。
【数据内容】
源站原始描述:What is this summary about? This article summarizes an economic evaluation of transcatheter aortic valve replacement (TAVR), a treatment for severe symptomatic aortic stenosis (SSAS). SSAS occurs when the aortic valve, which allows blood to leave the heart, becomes very narrow. This reduces blood flow to the body, causing symptoms like tiredness, chest pain, dizziness, or fainting. Treating SSAS requires replacing the valve. Untreated SSAS results in heart failure and death. Before TAVR, SSAS pa…
【数据结构与技术规格】
文件数 14 个,合计 14.98 MB。ijme_a_2403926_sm8164.png:image/png,534.61 KB。ijme_a_2403926_sm8163.png:image/png,1.84 MB。ijme_a_2403926_sm8162.pdf:application/pdf,1.95 MB。数据集 DOI:10.6084/m9.figshare.27258242.v1。
【主题与分类】
源站学科分类:Medicine、Genetics、Molecular Biology、Pharmacology、Chemical Sciences not elsewhere classified、Ecology。主题标签:Aortic stenosis、Economic evaluation、Treatment uptake、Value-for-money。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://tandf.figshare.com/articles/dataset/Transcatheter_aortic_valve_replacement_and_the_value_of_increasing_treatment_for_severe_symptomatic_aortic_stenosis_a_plain_language_summary/27258242
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Transcatheter aortic valve replacement and the value of increasing treatment for severe symptomatic aortic stenosis: a plain language summary. Taylor & Francis. Sevilla, J.P.; Russo, Mark J; Thompson, Christin A.; Jiao, Xiayu; Bloom, David E
【使用注意】
· 源站最后修改于 2026-03-17,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Transcatheter aortic valve replacement and the value of increasing treatment for severe symptomatic aortic stenosis: a plain language summary
- DOI:10.6084/m9.figshare.27258242.v1
- 发布日期:2024-10-18
- 文件数:14 个
- 文件总体积:14.98 MB
- 源站页面:https://tandf.figshare.com/articles/dataset/Transcatheter_aortic_valve_replacement_and_the_value_of_increasing_treatment_for_severe_symptomatic_aortic_stenosis_a_plain_language_summary/27258242
命令行下载
curl -L -o "ijme_a_2403926_sm8164.png" "https://ndownloader.figshare.com/files/49869008"
curl -L -o "ijme_a_2403926_sm8163.png" "https://ndownloader.figshare.com/files/49869011"
curl -L -o "ijme_a_2403926_sm8162.pdf" "https://ndownloader.figshare.com/files/49869014"
curl -L -o "ijme_a_2403926_sm8161.idml" "https://ndownloader.figshare.com/files/49869017"
curl -L -o "ijme_a_2403926_sm8160.png" "https://ndownloader.figshare.com/files/49869020"
curl -L -o "ijme_a_2403926_sm8159.png" "https://ndownloader.figshare.com/files/49869023"
curl -L -o "ijme_a_2403926_sm8158.png" "https://ndownloader.figshare.com/files/49869026"
curl -L -o "ijme_a_2403926_sm8157.indd" "https://ndownloader.figshare.com/files/49869029"
文件清单
ijme_a_2403926_sm8164.png(534.61 KB)ijme_a_2403926_sm8163.png(1.84 MB)ijme_a_2403926_sm8162.pdf(1.95 MB)ijme_a_2403926_sm8161.idml(263.99 KB)ijme_a_2403926_sm8160.png(669.70 KB)ijme_a_2403926_sm8159.png(407.33 KB)ijme_a_2403926_sm8158.png(438.10 KB)ijme_a_2403926_sm8157.indd(4.54 MB)ijme_a_2403926_sm8156.png(521.05 KB)ijme_a_2403926_sm8155.ttc(2.79 MB)ijme_a_2403926_sm8154.ttf(80.02 KB)ijme_a_2403926_sm8153.png(716.44 KB)ijme_a_2403926_sm8152.otf(218.64 KB)ijme_a_2403926_sm8151.lst(8.13 KB)
文件总体积 14.98 MB(源站 API 实测)。
数据说明
What is this summary about?
This article summarizes an economic evaluation of transcatheter aortic valve replacement (TAVR), a treatment for severe symptomatic aortic stenosis (SSAS). SSAS occurs when the aortic valve, which allows blood to leave the heart, becomes very narrow. This reduces blood flow to the body, causing symptoms like tiredness, chest pain, dizziness, or fainting. Treating SSAS requires replacing the valve. Untreated SSAS results in heart failure and death.
Before TAVR, SSAS patients had two options, medical management and surgical aortic valve replacement (SAVR). Medical management helps with symptoms but does not replace the valve, leading patients to eventually die from SSAS. SAVR replaces the valve through open-heart surgery, which is invasive, involving making a large cut through the chest bone. Concerns about this invasiveness led many patients to avoid SAVR, leaving their SSAS untreated. TAVR was introduced in 2010. It is less invasive than SAVR, involving inserting a new valve through a small cut in the leg. TAVR has become popular and twice as many patients now undergo TAVR compared to SAVR.
We measure TAVR’s net benefits as the value of its health benefits minus its healthcare costs. We measure these net benefits in three patient groups aged 65 and above in the United States. Group 1 patients are ineligible for SAVR, so TAVR is their only treatment option. Group 2 patients would have received SAVR if TAVR were not available. Group 3 patients are eligible for SAVR but concerned about its invasiveness, and so would have stayed untreated without TAVR.
Economic evaluation: A type of study that measures the benefits and costs of a treatment like TAVR and judges whether the benefits are sufficiently large to justify the costs (or put another way, whether the technology represents good value-for-money).
Transcatheter aortic valve replacement (TAVR): Replacement of the aortic valve in SSAS patients using a thin tube called a catheter that enters the body through a small cut near the leg and delivers and installs a valve replacement. New treatment option for SSAS from 2010 onwards. A minimally invasive treatment.
Aortic stenosis (AS): A
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.27258242.v1(source: https://tandf.figshare.com/articles/dataset/Transcatheter_aortic_valve_replacement_and_the_value_of_increasing_treatment_for_severe_symptomatic_aortic_stenosis_a_plain_language_summary/27258242)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




